Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

Share Price is delayed by 15 minutes
Get Live Data
88.50    -0.60 (-0.68%)
Bid:
88.00
Ask:
89.00
Spread: 1.00 (1.136%)
Market Cap: £59.03m
EAH Live PriceLast checked at - London Stock Exchange

Intraday Eco Animal Share Chart

Board Appointment

1 Dec 2021 07:00

RNS Number : 1112U
Eco Animal Health Group PLC
01 December 2021
 

1 December 2021

 

ECO Animal Health Group plc

 

("ECO" or the "Company") (AIM: EAH)

 

Board Appointment

 

 

ECO Animal Health Group plc, a leader in the development, registration and marketing of pharmaceutical products for global animal health market, is pleased to announce the appointment of Tracey James as a Non-Executive Director with immediate effect.

Tracey is a Chartered Accountant who has spent 26 years with Grant Thornton UK LLP, with the last 14 years as an Audit Partner. Tracey was a member of Grant Thornton's Oversight Board and also served on the Audit & Risk and Pensions Committees. She was also previously Finance Director of Karl Storz Endoscopy Canada (1999-2000). Tracey is currently a Non-Executive Director and Chair of the Audit Committee at specialist Engineering and Technology recruitment solutions business, Gattaca plc.

Tracey will join the Audit Committee of ECO.

Commenting on the appointment Andrew Jones, Chairman, said:

"I am delighted to welcome Tracey to the ECO Board. She has a strong financial background at senior level in Grant Thornton and brings with her a wealth of experience of growing businesses and AIM-listed companies."

 

Additional Information on the Board Appointment:

 

The following additional information is provided with regards to the appointment of Tracey Dawn James (née Clements), aged 58, in accordance with AIM Rule 17 and Schedule 2(g) of the AIM Rules for Companies:

Current directorships/partnerships:

 

Gattaca plc

 

Directorships/partnerships within the last five years:

 

Activate Learning Group (Charity)

Allenbuild Limited

Grant Thornton UK LLP

Millwood Designer Homes Limited

Modularwise Limited

Places for People Developments Limited

Places for People Group Limited

Places for People Ventures Limited

Places for People Ventures Operations Limited

Zeroc Group (2008) Limited

 

 

There are no further disclosures required to be made in respect of the appointment under AIM Rule 17 and Schedule 2(g) of the AIM Rules for Companies.

 

Contacts:

 

ECO Animal Health Group plc

Marc Loomes (CEO)

Christopher Wilks (CFO)

 

020 8447 6906

 

IFC Advisory

Graham Herring

Zach Cohen

 

020 3934 6630

 

Singer Capital Markets (Nominated Adviser & Joint Broker)

Mark Taylor

George Tzimas

 

020 7496 3000

Peel Hunt LLP (Joint Broker)

James Steel

Dr Christopher Golden

 

020 7418 8900

Equity Development

Hannah Crowe

Matt Evans

 

020 7065 2692

 

 

About ECO Animal Health

 

ECO Animal Health Group plc ("ECO" or "the Group") researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGZMFMRGKGMZM
Date   Source Headline
9th Oct 20247:00 amRNSIssue of Equity and TVR
1st Oct 20247:00 amRNSTrading Update
27th Sep 20242:21 pmRNSResult of AGM
30th Aug 20243:07 pmRNSDirector/PDMR Shareholding
29th Aug 20247:00 amRNSDeferred Share Option Award to Executive Directors
23rd Aug 20241:18 pmRNSHolding(s) in Company
16th Aug 20247:00 amRNSPosting of the Annual Report and Notice of AGM
12th Aug 20241:30 pmRNSBlock Listing Interim Review
15th Jul 20247:00 amRNSFinal Results
11th Jul 20249:30 amRNSNotice of Results
8th May 20247:00 amRNSRisk Profile Demonstrated for ECOVAXXIN MS
25th Apr 20247:00 amRNSTrading Update on year ended 31 March 2024
8th Apr 20247:00 amRNSHolding(s) in Company
4th Apr 20247:00 amRNSDisposal of non-core product line
22nd Mar 20247:00 amRNSShare Awards to Executive Directors
21st Mar 20249:13 amRNSReplacement: Trading Update
21st Mar 20247:00 amRNSTrading Update
19th Mar 20249:40 amRNSGeneral Meeting Result
27th Feb 20247:00 amRNSPublication of Notice of General Meeting
6th Feb 20247:00 amRNSTrademark Approval for ECOVAXXIN® family in the EU
8th Jan 20247:00 amRNSDisposal of Freehold Properties
5th Jan 20245:05 pmRNSHolding(s) in Company
5th Jan 20245:00 pmRNSHolding(s) in Company
22nd Dec 20237:00 amRNSDeferred Option Awards to Executive Directors
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
27th Nov 202310:00 amRNSInvestor Presentation
27th Nov 20237:00 amRNSResults for the six months ended 30 September 2023
14th Nov 20233:00 pmRNSHolding(s) in Company
9th Nov 20237:00 amRNSCapital Markets Day Events
24th Oct 20237:00 amRNSNew USA and Canada label claim for Aivlosin®
28th Sep 20237:00 amRNSESG Rating
7th Sep 20232:57 pmRNSResult of AGM
10th Aug 20237:00 amRNSNotice of AGM
21st Jul 20234:25 pmRNSPosting of the Annual Report and Accounts
10th Jul 20237:00 amRNSFinal Results for the Year Ended 31 March 2023
5th Jul 20237:00 amRNSNotice of Results & Investor Presentation
6th Jun 20237:00 amRNSIssue of Equity and Total Voting Rights
18th May 20237:00 amRNSHolding(s) in Company
23rd Mar 20237:00 amRNSTrading Update
8th Mar 20237:00 amRNSAnimal Health Innovation Summit
27th Feb 202310:37 amRNSDirector/PDMR Shareholding
24th Feb 20233:19 pmRNSChange of Registered Address
17th Feb 20231:41 pmRNSHolding(s) in Company
13th Feb 20231:55 pmRNSHolding(s) in Company
9th Feb 20237:00 amRNSHolding(s) in Company
9th Feb 20237:00 amRNSHolding(s) in Company
8th Feb 20237:00 amRNSDirector/PDMR Shareholding
20th Jan 202312:14 pmRNSHolding(s) in Company
13th Dec 20223:50 pmRNSDeferred Share Option Awards
30th Nov 20223:01 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.